Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results
/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," "we," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve...
Stay updated with breaking news from Lung Disease Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," "we," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve...
WHO estimates that about a quarter of the world’s population is infected with TB, with prevalence in Kenya at 140,000 infections.
Program/Project Management Consultancy in Kenya about Health, requiring 10+ years of experience, from CHS; closing on 11 Mar 2021
United Therapeutics Announces New England Journal of Medicine Publication of the INCREASE Study Evaluating Tyvaso® in Pulmonary Hypertension Associated with Interstitial Lung Disease INCREASE Study is First to Demonstrate a Clear Benefit in Patients with PH-ILD, a Life-threatening Disease with No Currently FDA-Approved Treatments Company to host a webcast detailing the INCREASE study results on Tuesday, January 19, 2021 at 4:30 p.m. E.T. News provided by Share this article Share this article SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 13, 2021 /PRNewswire/ -- United Therapeuti...
Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya Rose J. Kosgei , Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – original draft, Writing – review & editing Affiliation Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium ⨯ Peter Gichangi, Affiliation Department of Human Anatomy, University of Nairobi, Nairobi, Kenya ⨯ Marleen Temmerman, ...